|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.96 EUR | +0.49% |
|
+10.37% | -29.50% |
| Apr. 23 | Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 29 | Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024 |
Pharma Mar, S.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 44.53 million compared to EUR 65.13 million a year ago. Revenue was EUR 80.19 million compared to EUR 101.43 million a year ago.
Net income was EUR 6.44 million compared to EUR 34.92 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.50% | 545M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.36B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
PHARMA MAR, S.A. 
